Korea Stock Market Today, Oct 8, 2026: KOSPI -2.62% Despite Samsung Record Earnings

· HLB · KOSDAQ · KOSPI · Market Close · Samsung Electronics

Korea market close Oct 8, 2026: KOSPI 6,625.93 (-2.62%), KOSDAQ 892.27 (-0.69%)

KOSPI closed at 6,625.93, down 2.62%, and KOSDAQ closed at 892.27, down 0.69%, as foreign and institutional selling and a jump in U.S. long-term yields outweighed Samsung Electronics' record quarterly earnings; KOSDAQ held up better than the large-cap-heavy KOSPI. Individual themes moved on their own news: an exchange pause on delisting procedures for small-cap management issues, HLB's European review, and LG Energy Solution's record quarterly revenue.

IndexCloseChange
KOSPI6,625.93-2.62%
KOSDAQ892.27-0.69%

1. U.S. long-term yields and foreign selling — KOSPI falls over 2%, KOSDAQ holds up better

Korean markets weakened even though Samsung Electronics reported record quarterly earnings, as a surge in U.S. long-term Treasury yields and combined selling by foreign and institutional investors weighed on the market. KOSPI opened near 6,808 but selling widened through the session and the index closed at 6,625.93 (-2.62%). KOSDAQ fell more than 1% early on, then narrowed its losses to close at 892.27 (-0.69%), holding up better than the large-cap-heavy KOSPI.

2. Exchange pauses delisting procedures for market-cap shortfalls — management issues surge

Management-designated stocks jumped after the Korea Exchange said it would suspend follow-up delisting procedures for companies that fell short of the market capitalization requirement, following a court decision suspending the effect of those delistings. The management designation itself stays, but delisting on market-cap grounds is on hold until the lawsuit is resolved. The rule that delists stocks trading under 1,000 won is unchanged, so not every delisting risk has gone away. Hyungji I&C, Eugene Technology, CS, Newintec, Bio-Infra, Yeseon Tech and Hyungji Global rose to or near the daily limit, and buying spread to other market-cap-shortfall issues such as Moadata, Engenbio and Newbotec.

3. HLB's bile duct cancer drug — EMA starts full review, HLB group stocks in focus

HLB group stocks drew attention again after the company's bile duct cancer drug rivoceranib's full European marketing review began at the European Medicines Agency (EMA), following U.S. FDA approval. HLB's U.S. subsidiary Elevar applied for European marketing authorization on September 14 and was told within 15 days that the full review had started. Buying came into HLB Pharma, HLB Biostep, HLB Panagene, HLB Global, HLB Therapeutics and HLB Life Science on hopes of extending commercialization to Europe. A started review is not an approval.

4. LG Energy Solution posts record quarterly revenue — ESS and battery stocks strengthen

Sentiment toward battery stocks improved after LG Energy Solution reported record quarterly revenue of 9.6434 trillion won for the third quarter, with operating profit rising to 756.0 billion won. The drivers were expanding ESS (energy storage) business in North America and a recovery in EV battery shipments, and rapidly growing ESS demand from AI data centers was seen as a new growth axis beyond EVs. LG Energy Solution and Samsung SDI strengthened, and buying spread to materials, equipment and parts names including Sama Aluminium, Nine Tech, HT Robotics, Megatouch, Pino, WPC, EcoPro BM, EcoPro and Aekyung Chemical.

5. AI and memory investment hopes — rotation into KOSDAQ chip equipment and materials

While large chip stocks such as Samsung Electronics and SK Hynix were weighed down by the index decline on KOSPI, KOSDAQ chip equipment, materials and test stocks saw strong rotation. Continued expectations for AI server and memory capacity expansion fed hopes that benefits will extend from front-end to back-end to test and inspection equipment. Doosan Tesna, Wonik IPS, Jusung Engineering, PSK, Soulbrain Holdings, Nepes, DKT and Daewon NexView were in focus, and some of them, including Doosan Tesna, Jusung Engineering and Daewon NexView, rose by double digits intraday.

Quick FAQ

Why did KOSPI fall on Oct 8 despite Samsung's record earnings?
A surge in U.S. long-term Treasury yields and combined selling by foreign and institutional investors outweighed the earnings news, and KOSPI closed at 6,625.93 (-2.62%).

Why did management-designated stocks jump together?
The Korea Exchange said it would pause follow-up delisting procedures for market-cap shortfalls until the related lawsuit is resolved. The rule delisting stocks under 1,000 won remains in place.

What does the EMA's full review mean for HLB?
It means the European Medicines Agency has started a full review of the marketing application. It is not an approval.

This brief is our own summary based on same-day Korean market coverage and Daum Finance closing data; it is not a translation and not investment advice. See our Disclaimer and evidence labels.
Stock Anatomy · Last checked: October 8, 2026

Related